Scientific publications
1. Gulei D, Indini A, Jerónimo C, Iuga CA, Grossi F. Cancer Mechanisms and Emerging Therapies. Pharmaceutics. 2021 Jul 9;13(7):1045. doi: 10.3390/pharmaceutics13071045. PMID: 34371736; PMCID: PMC8308996
2. Kegyes D, Constantinescu C, Vrancken
L, Rasche
L, Gregoire C, Tigu B, Gulei
D,
Dima D, Tanase
A, Einsele
H, Ciurea
S, Tomuleasa
C, Caers
J. Patient selection for CAR T or BiTE therapy in multiple myeloma: Which
treatment for each patient? J Hematol
Oncol. 2022 Jun 7;15(1):78. doi: 10.1186/s13045-022-01296-2. PMID:
35672793; PMCID: PMC9171942.
3. Qian L, Xia X, Liu J, Chen X, Liu Y,
Wang X, Iluta
S, Pasca
S, Gulei
D,
Tomuleasa C. Characterization of extrachromosomal circular DNA in patients with
acute myeloid leukemia: proof-of-concept report using cohorts from Beijing and
Shanghai. Ann Transl Med. 2022 Aug;10(15):843. doi:
10.21037/atm-22-1498. PMID: 36035011; PMCID: PMC9403928.
4. Munteanu R, Feder RI, Onaciu
A, Munteanu VC, Iuga CA, Gulei D.
Insights into the Human Microbiome and Its Connections with Prostate Cancer.
Cancers (Basel). 2023 Apr 28;15(9):2539. doi: 10.3390/cancers15092539. PMID:
37174009; PMCID: PMC10177521
5. Kegyes D, Gulei
D,
Drula
R, Cenariu
D, Tigu
B, Dima D, Tanase
A, Badelita
S, Buzoianu
AD, Ciurea
S, Ghiaur
G, Terpos
E, Ciechanover A, Einsele H, Tomuleasa C. Proteasome
inhibition in combination with immunotherapies: State-of-the-Art in multiple
myeloma. Blood Rev. 2023 Sep;61:101100. doi: 10.1016/j.blre.2023.101100. Epub
2023 May 27. PMID: 37291017.
6. Constantinescu C, Constantinescu R, Bergthorsson
JT,
Greiff
V,
Tanase
A, Colita
A, Gulei
D,
Tomuleasa C. Pitfalls in patenting academic CAR-T cells therapy. Expert Opin
Ther
Pat. 2023 Jan-Jun;33(5):339-348. doi: 10.1080/13543776.2023.2220883. Epub
2023 Jun 6. PMID: 37254751.
7. Tigu AB, Hotea I, Drula R, Zimta AA, Dirzu N, Santa M, Constantinescu C, Dima
D, Bergthorsson
JT,
Greiff
V,
Gulei
D,
Coriu
D, Serban
M, Mahlangu J, Tomuleasa C. RNA sequencing suggests that non-coding RNAs play a
role in the development of acquired haemophilia.
J Cell Mol Med. 2023 Jul;27(13):1790-1796. doi: 10.1111/jcmm.17741. Epub
2023 Jun 14. PMID: 37317065; PMCID: PMC10315746.
8. Tigu
AB, Constantinescu CS, Teodorescu P, Kegyes
D, Munteanu R, Feder R, Peters M, Pralea I, Iuga C, Cenariu
D, Marcu
A, Tanase
A, Colita
A, Drula
R, Bergthorsson
JT,
Greiff
V,
Dima D, Selicean
C, Rus I, Zdrenghea
M, Gulei
D,
Ghiaur
G, Tomuleasa C. Design and preclinical testing of an anti-CD41 CAR T cell for
the treatment of acute megakaryoblastic
leukaemia.
J Cell Mol Med. 2023 Oct;27(19):2864-2875. doi: 10.1111/jcmm.17810. Epub
2023 Sep 4. PMID: 37667538; PMCID: PMC10538266